LP
Lantern Pharma Inc
🇺🇸XNAS.LTRNUnited StatesHealthcare
$1.79USDup +0.09 (+5.29%)OpenDelayed6:07 PM
Price$1.79+0.09 (+5.29%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US51654W1018
- CUSIP
- 51654W101
Company
- Employees
- 16
- Headquarters
- Dallas, United States
- CEO
- Mr. Panna Sharma
Market
- Shares outstanding
- 12.8M
- Market cap
- $22.88M
Highlights
- Market cap
- $21.86M
- EPS LTM
- -$1.50
- P/E LTM
- -2.65
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$18.65M+3.1%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$14.08M+21.24%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.